Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like One-Time CAR-T Leader Juno Shows Off Promising New Clinical Data November 1, 2017 3 FDA Decisions to Look Out for in February January 31, 2018 GENFIT Reaches A Critical Milestone Towards The Development Of A Non-Invasive In Vitro Diagnostic (IVD) Test For NASH June 22, 2017
GENFIT Reaches A Critical Milestone Towards The Development Of A Non-Invasive In Vitro Diagnostic (IVD) Test For NASH June 22, 2017